Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Cites (278)

Items 201–278 of 278

1. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study
   Elder, Douglas H.J., Singh, Jagdeep S.S., Levin, Daniel, Donnelly, Louise A., Choy, Anna-Maria, George, Jacob, Struthers, Allan D., Doney, Alex S.F., Lang, Chim C. · 2016 · European Journal of Heart Failure
2. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database
   Gian Paolo Fadini, Angelo Avogaro, Luca Degli Esposti, Pierluigi Russo, Stefania Saragoni, Stefano Buda, Giuseppe M.C. Rosano, S. Pecorelli, Luca Pani · 2015 · European Heart Journal
3. Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up
   Johan Ärnlöv, Lars Lind, Björn Zethelius, Bertil Andrén, Charles Nicholas Hales, Bengt OH Vessby, Hans Lithell · 2001 · American Heart Journal
4. Outcomes of Simultaneous Heart–Kidney Transplant in the US: A Retrospective Analysis Using OPTN/UNOS Data
   Jagbir Gill, T. Shah, I. Hristea, Disaya Chavalitdhamrong, Bishoy Anastasi, S. Takemoto, Suphamai Bunnapradist · 2009 · American Journal of Transplantation
5. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes
   Akio Monji, Toko Mitsui, Yoshiyuki Bando, Morihiko Aoyama, Toshimasa Shigeta, Toyoaki Murohara · 2013 · American Journal of Physiology-Heart and Circulatory Physiology
6. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus
   Shuo‐Ming Ou, Chia-Jen Shih, Pei-Wen Chao, Hsi Chu, Shu‐Chen Kuo, Yi-Jung Lee, Shuu‐Jiun Wang, Chih‐Yu Yang, Chih‐Ching Lin, Tzeng‐Ji Chen et al. · 2015 · Annals of Internal Medicine
7. The Risk of Heart Failure in Patients with Type 2 Diabetes Treated with Oral Agent Monotherapy
   Finlay Aleck McAlister, Dean T. Eurich, Sumit R. Majumdar, Jeffrey A. Johnson · 2008 · European Journal of Heart Failure
8. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes
   Marcus Lind, Marita Olsson, Anders H. Rosengren, Ann‐Marie Svensson, Ioannis Bounias, Soffia Guðbjörnsdóttir · 2012 · Diabetologia
9. Metformin Therapy and Outcomes in Patients With Advanced Systolic Heart Failure and Diabetes
   Shah, Digish D., Fonarow, Gregg C., Horwich, Tamara B. · 2010 · Journal of Cardiac Failure
10. Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
    Isabelle Johansson, Ulf Dahlström, Magnus Edner, Per Näsman, Lars Rydén, Anna Norhammar · 2016 · Journal of the American College of Cardiology
11. Functional class in patients with heart failure is associated with the development of diabetes
    Tenenbaum, Alexander, Motro, Michael, Fisman, Enrique Z, Leor, Jonathan, Freimark, Dov, Boyko, Valentina, Mandelzweig, Lori, Adler, Yehuda, Sherer, Yaniv, Behar, Solomon · 2003 · The American Journal of Medicine
12. Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities
    Benjamin Adam Steinberg, Sana M. Al‐Khatib, Rex Edwards, JooYoon Han, Gust H. Bardy, J. Thomas Bigger, Alfred E. Buxton, Arthur J. Moss, Kerry L. Lee, Richard C. Steinman et al. · 2014 · JACC Heart Failure
13. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly–adenosine diphosphate–ribose polymerase
    Mohammed Fiyaz Chowdhry, Hunaid Ahmed Vohra, Manuel Galiñanes · 2007 · Journal of Thoracic and Cardiovascular Surgery
14. Pioglitazone and Heart Failure: Results From a Controlled Study in Patients With Type 2 Diabetes Mellitus and Systolic Dysfunction
    Thomas D. Giles, Alan Bruce Miller, Uri Elkayam, Mondira Bhattacharya, Alfonso Pérez · 2008 · Journal of Cardiac Failure
15. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus
    Paul R. Conlin, Jeffrey A. Colburn, David Clark Aron, Rose Mary Pries, Mark P. Tschanz, LEONARD M. POGACH · 2017 · Annals of Internal Medicine
16. Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
    D. Nathanson, Bengt Ullman, Ulrika Löfström, ANDERS G. HEDMAN, Mats Frick, Åke Sjöholm, Thomas Nyström · 2012 · Diabetologia
17. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
    Christianne L. Roumie, Jea Young Min, Lucy D’Agostino McGowan, Caroline A. Presley, Carlos G. Grijalva, Amber J. Hackstadt, Adriana M. Hung, Robert A. Greevy, Tom A. Elasy, Marie R. Griffin · 2017 · Journal of the American Heart Association
18. Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
    Josie M. M. Evans, Alex S. F. Doney, Matlooba A. AlZadjali, Simon Alexander Ogston, John R. Petrie, Andrew D. Morris, Allan D. Struthers, Aaron Wong, Chim Choy Lang · 2010 · The American Journal of Cardiology
19. HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study
    Pazin-Filho, A., Kottgen, A., Bertoni, A. G., Russell, S. D., Selvin, E., Rosamond, W. D., Coresh, J. · 2008 · Diabetologia
20. Concomitant Diabetes Mellitus and Heart Failure
    Alessandra Dei, Gregg C. Fonarow, Mihai Gheorghiade, Javed Butler · 2014 · Current Problems in Cardiology
21. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure
    Peter Swoboda, Adam Kenneth McDiarmid, Bara Erhayiem, David Paul Ripley, Laura Elizabeth Dobson, Pankaj Garg, Tarique A Musa, Klaus Karl Witte, Mark T. Kearney, Julian H. Barth et al. · 2017 · Journal of the American Heart Association
22. Weight Loss in Obese Patients With Heart Failure
    Zamora, Elisabet, Díez‐López, Carles, Lupón, Josep, de Antonio, Marta, Domingo, Mar, Santesmases, Javier, Troya, María Isabel, Díez‐Quevedo, Crisanto, Altimir, Salvador, Bayes‐Genis, Antoni · 2016 · Journal of the American Heart Association
23. Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial
    Bowling, C. Barrett, Sanders, Paul W., Allman, Richard M., Rogers, William J., Patel, Kanan, Aban, Inmaculada B., Rich, Michael W., Pitt, Bertram, White, Michel, Bakris, George C. et al. · 2013 · International Journal of Cardiology
24. Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure
    Thomas Langenickel, William P. Dole · 2012 · Drug Discovery Today Therapeutic Strategies
25. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
    Preiss, David, van Veldhuisen, Dirk J., Sattar, Naveed, Krum, Henry, Swedberg, Karl, Shi, Harry, Vincent, John, Pocock, Stuart J., Pitt, Bertram, Zannad, Faiez et al. · 2012 · European Journal of Heart Failure
26. Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
    Komajda, Michel, Tavazzi, Luigi, Francq, Bernard G., Böhm, Michael, Borer, Jeffrey S., Ford, Ian, Swedberg, Karl · 2015 · European Journal of Heart Failure
27. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
    Preiss, David, Zetterstrand, Sofia, McMurray, John J.V., Östergren, Jan, Michelson, Eric L., Granger, Christopher B., Yusuf, Salim, Swedberg, Karl, Pfeffer, Marc A., Gerstein, Hertzel C. et al. · 2009 · Diabetes Care
28. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population
    Claire Alexandra Lawson, Peter W. Jones, Lucy Teece, Sandra Barker Dunbar, Petar M Seferovic, Kamlesh K. Khunti, Mamas A. Mamas, Umesh T. Kadam · 2017 · JACC Heart Failure
29. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS
    James Henry O’Keefe, Hussam S. Abuissa, Bertram Pitt · 2007 · Diabetes Obesity and Metabolism
30. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy
    Suzanne V. Arnold, Philip G. Jones, Larry A. Allen, David J. Cohen, Timothy J. Fendler, Jonathan E. Holtz, Sanjeev A. Aggarwal, John A. Spertus · 2016 · Circulation Heart Failure
31. Risk Factors for Hyperkalaemia in a Cohort of Patients with Newly Diagnosed Heart Failure: A Nested Case–Control Study in UK General Practice
    Alexander Michel, Mar Martín‐Pérez, Ana Ruigómez, Luis Alberto García Rodríguez · 2015 · European Journal of Heart Failure
32. Improved Diabetic Control in Advanced Heart Failure Patients Treated with Left Ventricular Assist Devices
    Nir Y. Uriel, Yoshifumi Naka, P.C. Colombo, MARYJANE A. FARR, Sang‐Woo Pak, Vlad Cotarlan, Jeanine Albu, Dympna Gallagher, DONNA M. MANCINI, Henry N. Ginsberg et al. · 2010 · European Journal of Heart Failure
33. Metformin: safety in cardiac patients
    R Khurana, Iqbal Saeed Malik · 2009 · Postgraduate Medical Journal
34. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis
    Bell, David S. H., Ann Lukas, Mary, Holdbrook, Frederick K., Fowler, Michael B. · 2006 · Current Medical Research and Opinion
35. Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
    ORIGIN Trial Investigators · 2015 · Diabetes Care
36. Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy
    Mark T. Waddingham · 2015 · World Journal of Diabetes
37. Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
    Sotero P. Romero, José L. Andrey, Antonio A. Garcia-Egido, Miguel A. Escobar, Virginia Perez, Ramón Corzo, Gloria J. Garcia-Domiguez, Francisco Gomez · 2011 · International Journal of Cardiology
38. Effect of Orlistat in Obese Patients With Heart Failure: A Pilot Study
    Luís Beck da Silva Neto, Lyall Higginson, Margaret Fraser, Kathryn Williams, Haissam A. Haddad · 2005 · Congestive Heart Failure
39. Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus
    Helen Parry, Harshal Deshmukh, Daniel Levin, Natalie Van Zuydam, Douglas H.J. Elder, Andrew D. Morris, Allan D. Struthers, Colin N.A. Palmer, Alex S. F. Doney, Chim Choy Lang · 2015 · Circulation Heart Failure
40. Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data: a population‐ and insurance‐based cohort
    Sascha Abbas, Peter Ihle, Sebastian Harder, Ingrid Schübert · 2015 · Pharmacoepidemiology and Drug Safety
41. Risk Factors for Development of New-Onset Diabetes Mellitus in Adult Heart Transplant Recipients
    Xiaoyi Ye, Hung‐Tien Kuo, MS Sampaio, Yan Jiang, Pavani Naini Reddy, Suphamai Bunnapradist · 2010 · Transplantation
42. Efficacy of Ivabradine, a Selective If Inhibitor, in Patients With Chronic Stable Angina Pectoris and Diabetes Mellitus
    JEFFREY S. BORER, Jean‐Claude Tardif · 2009 · The American Journal of Cardiology
43. Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure
    Stefania Paolillo, Giuseppe Rengo, Teresa Pellegrino, Roberto Formisano, Gennaro Pagano, Paola Gargiulo, Gianluigi Savarese, Raffaela Maria Carotenuto, Laura Petraglia, Antonio Rapacciuolo et al. · 2015 · European Heart Journal - Cardiovascular Imaging
44. The effect of liraglutide on endothelial function in patients with type 2 diabetes
    Debashis K. Nandy, Christopher Johnson, Rita Basu, Michael J. Joyner, Jason Brett, Claus Bo Svendsen, Ananda Basu · 2014 · Diabetes and Vascular Disease Research
45. Response to exercise training and outcomes in patients with heart failure and diabetes mellitus: insights from the HF-ACTION trial
    Banks, Adam Z., Mentz, Robert J., Stebbins, Amanda, Mikus, Catherine R., Schulte, Phillip J., Fleg, Jerome L., Cooper, Lawton S., Leifer, Eric S., Badenhop, Dalynn T., Keteyian, Steven J. et al. · 2016 · Journal of Cardiac Failure
46. Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
    Lincoff, A. Michael, Wolski, Kathy, Nicholls, Stephen J., Nissen, Steven E. · 2007 · JAMA
47. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)
    Martin, David T., McNitt, Scott, Nesto, Richard W., Rutter, Martin K., Moss, Arthur J. · 2011 · Circulation Heart Failure
48. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure
    Ghali, Jalal k., Boehmer, John, Feldman, Arthur M., Saxon, Leslie A., Demarco, Teresa, Carson, Peter, Yong, Patrick, Galle, Elizabeth G., Leigh, Jill, Ecklund, Fred L. et al. · 2007 · Journal of Cardiac Failure
49. A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes
    Sandra Barker Dunbar, Brittany Butts, Carolyn Miller Reilly, REBECCA A. GARY, Melinda Kay Higgins, Erin Poe Ferranti, Steven D. Culler, Javed Butler · 2013 · Nursing Outlook
50. Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes
    Saul Blecker, Hannah Park, Stuart D. Katz · 2016 · BMC Cardiovascular Disorders
51. Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus
    Young‐Gun Kim, Dukyong Yoon, Soo-Young Park, Seung Jin Han, Dae Jung Kim, Kwan Woo Lee, Rae Woong Park, Hae Jin Kim · 2017 · Circulation Heart Failure
52. Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
    Bryan Wai, Leighton G Kearney, David L. Hare, Michelle Ord, Louise M. Burrell, Piyush Srivastava · 2012 · Cardiovascular Diabetology
53. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure
    Hoppe, Uta C., Freemantle, Nick, Cleland, John G.F., Marijianowski, Monique, Erdmann, Erland · 2007 · Diabetes Care
54. Risk Factors for Adverse Outcomes by Left Ventricular Ejection Fraction in a Contemporary Heart Failure Population
    Larry A. Allen, David J. Magid, Jerry H. Gurwitz, David H. Smith, Robert Joel Goldberg, Jane S. Saczynski, Micah L. Thorp, Grace Hsu, Sue Hee Sung, Alan S. Go · 2013 · Circulation Heart Failure
55. Health‐related quality of life of patients with severe heart failure. A cross‐sectional multicentre study
    Nikolaos V. Fotos, Konstantinos Giakoumidakis, Zoi Kollia, Petros Galanis, Panagiota Copanitsanou, Evangelia Pananoudaki, Hero Brokalaki · 2012 · Scandinavian Journal of Caring Sciences
56. HbA1c and Heart Failure Risk Among Diabetic Patients
    Wenhui Zhao, Peter Todd Katzmarzyk, Ronald L. Horswell, Yujie Wang, Jolene L. Johnson, Gang Hu · 2013 · The Journal of Clinical Endocrinology & Metabolism
57. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices
    Rabea Asleh, Αlexandros Briasoulis, Sarah D. Schettle, Vakhtang Tchantchaleishvili, Naveen L. Pereira, Brooks S. Edwards, Alfredo L. Clavell, Simon Maltais, David L. Joyce, Lyle D. Joyce et al. · 2017 · Circulation Heart Failure
58. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation
    Amanda R. Vest, Stanley M. Mistak, Rory Hachamovitch, Maria Mountis, Nader Moazami, James B. Young · 2016 · Journal of Cardiac Failure
59. Comparison of Efficacy of Implanted Cardioverter-Defibrillator in Patients With Versus Without Diabetes Mellitus
    Stephen M. Wittenberg, James R. Cook, William Jackson Hall, Scott A McNitt, Wojciech Zaręba, Arthur J. Moss · 2005 · The American Journal of Cardiology
60. Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy
    Michael S. Kiernan, Kartik S. Sundareswaran, Duc Thinh Pham, Navin Kumar Kapur, Naveen L. Pereira, Martin Strueber, David J. Farrar, David D. DeNofrio, Joseph G. Rogers · 2016 · Journal of Cardiac Failure
61. Spironolactone and glucose metabolism, a systematic review and meta-analysis of randomized controlled trials
    Jie V. Zhao, Lin Xu, Shi Lin Lin, Catherine Mary Schooling · 2016 · Journal of the American Society of Hypertension
62. Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later
    Johan Ärnlöv, Lars Lind, Johan Sundström, Bertil Andrén, Bengt OH Vessby, Hans Lithell · 2005 · Nutrition Metabolism and Cardiovascular Diseases
63. Augmentation of Glucagon-Like Peptide-1 Receptor Signalling by Neprilysin Inhibition: Potential Implications for Patients with Heart Failure
    Milton Packer · 2018 · European Journal of Heart Failure
64. Diabetes and Outcomes After Left Ventricular Assist Device Placement
    Javed Butler, Renee L. Howser, Peer M. Portner, Richard N. Pierson · 2005 · Journal of Cardiac Failure
65. Weight loss and quality of life in chronic heart failure patients
    Rita Mariotti, F CASTROGIOVANNI, Maria Laura Canale, Gabriele Borelli, Lorenzo Rondinini · 2008 · Journal of Cardiovascular Medicine
66. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level
    Ichiro Kishimoto, Hisashi Makino, Yoko Ohata, Tamiko Tamanaha, Mayu Tochiya, Akiko Kada, Masaharu Ishihara, Toshihisa Anzai, Wataru Shimizu, Satoshi Yasuda et al. · 2014 · Diabetes Research and Clinical Practice
67. Aliskiren Alone or in Combination with Enalapril vs. Enalapril Among Patients with Chronic Heart Failure with and without Diabetes: A Subgroup Analysis from the ATMOSPHERE Trial
    Søren Lund Kristensen, Ulrik Madvig Mogensen, Georgia Tarnesby, Claudio R. Gimpelewicz, Mohammed A. Ali, Qing Shao, YannTong Chiang, Pardeep S. Jhund, William T. Abraham, Kenneth Dickstein et al. · 2017 · European Journal of Heart Failure
68. Improvement in Blood Glucose Control in Patients With Diabetes After Implantation of Left Ventricular Assist Devices
    Maya E. Guglin, Kim Maguire, Taylor Missimer, Cristiano Faber, Christiano Caldeira · 2014 · ASAIO Journal
69. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease
    Priyesh Ashok Patel, Li Liang, Prateeti Khazanie, Bradley G. Hammill, Gregg C. Fonarow, Clyde W. Yancy, Deepak L. Bhatt, Lesley H. Curtis, Adrian F. Hernandez · 2016 · Circulation Heart Failure
70. Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.
    Saumya Kankanala, Rafay M. Syed, Quan Gong, Boxu Ren, Xiaoquan Rao, Jixin Zhong · 2016 · PubMed Central
71. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes
    Rury R. Holman, Mary Angelyn Bethel, Adrian F. Hernandez · 2017 · New England Journal of Medicine
72. Does Carvedilol Impair Insulin Sensitivity in Heart Failure Patients Without Diabetes?
    Stefania Ferrua, Marco Bobbio, Elisa Catalano, Giorgio Grassi, N Massobrio, Silvia Pinach, C Rossi, Massimo Veglio, Gian Paolo Trevi · 2005 · Journal of Cardiac Failure
73. Usefulness of Hemoglobin A1c to Predict Outcome After Cardiac Resynchronization Therapy in Patients With Diabetes Mellitus and Heart Failure
    Ravi V. Shah, Robert Altman, Mi Young Park, Jodi L. Zilinski, Jordan S Leyton-Mange, Mary P. Orencole, Michael H. Picard, Conor D. Barrett, Edwin Kevin Heist, Gaurav A. Upadhyay et al. · 2012 · The American Journal of Cardiology
74. How Should Subgroup Analyses Affect Clinical Practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
    John Wikstrand, Hans Wedel, Jalal K. Ghali, PRAKASH C. DEEDWANIA, Björn Fagerberg, Sidney Goldstein, Stephen S. Gottlieb, Åke C. Hjalmarson, JOHN K. KJEKSHUS, Finn Waagstein · 2003 · Cardiac Electrophysiology Review
75. Improvement in Glycemic Control After Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients With Diabetes Mellitus
    Naila Choudhary, Leway Chen, Lisa Kotyra, Steven D. Wittlin, Jeffrey D. Alexis · 2014 · ASAIO Journal
76. Management of newly treated diabetes in Medicare beneficiaries with and without heart failure
    Lauren Beth Cooper, Xiaojuan Mi, Robert John Mentz, Jennifer B. Green, Kevin Joseph Anstrom, Adrian F. Hernandez, Lesley H. Curtis · 2016 · Clinical Cardiology
77. Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes
    Stanko Skrtic, Claudia S. Cabrera, Marita Olsson, Volker Schnecke, Marcus Lind · 2016 · Heart
78. Positive Impact of Continuous‐Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure
    Debbie C. Yen, Mara H. Watson, Lindsey D. Burgess, Maragatha N. Kuchibhatla, Chetan B. Patel, Kristen Bova Campbell, Alyssa K. Vora · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy